Contacts and Special Interests
Release Date: May 05, 2020
Expiration Date: May 8, 2023
R01 Clinical Trial Required Participating Institutes and Centers
- NIH Institutes and Centers that accept Investigator-Initiated R01 applications in response to the Parent R01 Clinical Trial Required Announcement - (PA-20-NNN): NHGRI, NEI, NIA, NIAAA, NIAID, NIDA, NIDCD, NIEHS, NIGMS, NIMHD, NINR, NICHD
- NIH Institutes and Centers that only accept Investigator-Initiated R01 applications proposing mechanistic clinical trials in response to the Parent R01 Clinical Trial Required Announcement (PA-20-NNN): NCCIH, NHLBI, NIAMS, NIMH, NINDS
- NIH Institutes and Centers that DO NOT ACCEPT applications in response to the Parent R01 Clinical Trial Required Announcement but ONLY accept R01 applications proposing clinical trial(s) in response to their specific funding opportunity announcements: NCI, NIBIB, IDCR, NLM, FIC, NCATS
NIH Institute/Center Contacts | Scientific/Research Contact Institute/Center Specific Information | Financial or Grants Management Contact | |
---|---|---|---|
National Center for Complementary and Integrative Health (NCCIH) | Wendy Weber, ND, PhD, MPH National Center for Complementary and Integrative Health (NCCIH) Telephone: 301-402-1272 Email: weberwj@mail.nih.gov |
Shelley Carow National Center for Complementary and Integrative Health (NCCIH) Telephone: 301-594-3788 Email: carows@mail.nih.gov |
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | NICHD Referral Office Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Email: NICHDReferral@mail.nih.gov The NICHD supports research in areas relevant to normal and abnormal human development, including contraception, fertilization, pregnancy, childbirth, prenatal and postnatal development; childhood development through adolescence; intellectual and developmental disabilities; and rehabilitation medicine. https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/default.aspx. Grant applications and project proposals must fall within the missions of the scientific branches of NICHD's Division of Extramural Research or its National Center for Medical Rehabilitation Research. Potential applicants are strongly encouraged to visit these pages for recent scientific advances and emerging public health topics. If you have questions about projects within a specific research area, you may find an NICHD program officer at https://www.nichd.nih.gov/grants-contracts/research-areas/priorities |
Margaret Young Grants Management Branch Telephone: 301-642-4552 Email: margaret.young@nih.gov |
|
National Eye Institute
(NEI) |
Ellen Liberman, PhD
|
Karen Robinson Smith National Eye Institute (NEI) Telephone: 301-451-2020 Email: Karen.Robinson.Smith@nei.nih.gov |
|
National Human Genome Research Institute (NHGRI) | Jennifer Troyer, Ph.D. Telephone: 301-312-3276 Email: troyerj@mail.nih.gov NHGRI will support the development of resources, approaches, and technologies that will accelerate GENOMIC research on the structure of genomes, the biology of genomes, and the biology of disease; that will advance the science of genomic medicine; and that will incorporate genomics to improve the effectiveness of healthcare. NHGRI will also support GENOMIC research in several cross-cutting areas, including the ethical, legal and societal implications of genomics and genetics research, bioinformatics, technology development, and research training and career development. In general, NHGRI supports studies that provide generalizable methods and knowledge. Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. NHGRI strongly encourages potential applicants to contact program staff in the early stages of developing your application. The contact information for the three scientific programs are: Division of Genome Science: https://www.genome.gov/27550609/division-of-genome-sciences-staff/ Division of Genomic Medicine: https://www.genome.gov/27550610/division-of-genomic-medicine-staff/ Division of Genomics and Society: https://www.genome.gov/27550080/division-of-genomics-and-society/ |
Deanna L. Ingersoll Telephone: 301-435-7858 Email: Deanna.Ingersoll@nih.gov |
|
National Heart, Lung, and Blood Institute
(NHLBI) |
As announced in NOT-HL-19-690, NHLBI will accept applications in
response to the NIH Parent (R01 Clinical Trial Required) FOA that propose:
Please refer to NOT-HL-19-690 for additional
information/clarification.
Division of Blood Diseases and Resources Email: NHLBIDBDRGrantResource@nhlbi.nih.gov Telephone: 301-435-0080
|
Taryn Cobb Telephone: 301-827-8025 Email: taryn.cobb@nih.gov |
|
National Institute on Aging (NIA) | Rene Etcheberrigaray, M.D. National Institute on Aging (NIA) Telephone: 301-451-9798 Email: rene.etcheberrigaray@nih.gov |
Traci Lafferty National Institute on Aging (NIA) Telephone: 301-496-8987 Email: laffertt@nia.nih.gov |
|
National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Division of Epidemiology and Prevention Research Gregory Bloss Telephone: 301-443-3865 Email: gbloss@mail.nih.gov Division of Medications Development Research Joanne B. Fertig, Ph.D. Telephone: 301-443-0635 Email: jfertig@mail.nih.gov Division of Metabolism and Health Effects Svetlana Radaeva, Ph.D. Telephone: 301-443-1189 Email: sradaeva@mail.nih.gov Division of Neuroscience and Behavior John Matochik, Ph.D. Telephone: 301-451-7319 Email: jmatochi@mail.nih.gov |
Judy Fox Telephone: 301-443-4704 Email: jfox@mail.nih.gov |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
As announced in NOT-AI-21-037, NIAID accepts clinical trial applications
submitted under PA-20-183 that are not “high-risk”. A “high-risk” clinical trial is defined by
NIAID as having one or more of the following attributes:
Applicants proposing “high-risk” clinical trials should not submit to this FOA. Instead
applicants proposing “high-risk” clinical trials should refer to NIAID Investigator-Initiated Clinical Trial
Resources. Applicants are strongly encouraged to consult the NIAID
Scientific/Research Contact listed here prior to submission to confirm the appropriateness of the
proposed project for this funding opportunity.
Mr. Martin Gutierrez
|
Regina Kitsoulis National Institute of Allergy and Infectious Diseases (NIAID) Telephone: 240-669-2946 Email: regina.kitsoulis@nih.gov |
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | As announced in NOT-AR-18-008,
NIAMS only accepts clinical trial applications proposing mechanistic studies for the Research Project
Grant (Parent R01 Clinical Trial Required) (PA-19-055). Applicants who wish to submit clinical trial
applications for consideration by NIAMS should not submit the application to this FOA. Instead,
applicants must submit clinical trial applications to one of the FOAs listed at http://www.niams.nih.gov/Funding/Clinical_Research/clinical_main.asp.
Applicants are strongly advised to consult with NIAMS program staff prior to submitting an application
with human subjects to determine the appropriate funding opportunity For information regarding NIAMS supported scientific areas/programs and contacts, please see: https://www.niams.nih.gov/grants-funding/supported-scientific-areas. |
|
|
National Institute on Drug Abuse (NIDA) | Yuki Lama, PhD Phone: 301-443-4577 NIDAreferral@mail.nih.gov |
Pam Fleming Email: pfleming@nida.nih.gov Telephone: 301-480-1159 |
|
National Institute of Biomedical Imaging and Bioengineering (NIBIB) | Moria Bittmann, Ph.D. 301-451-4778 moria.bittmann@nih.gov |
Katie Ellis Phone: 301-451-4791 Email: kellis@mail.nih.gov |
|
National Institute on Deafness and Other Communication Disorders (NIDCD) | https://www.nidcd.nih.gov/about/staff-organization/division-of-scientific-programs | Christopher Myers Telephone: 301-402-0909 Email: myersc@mail.nih.gov |
|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Division of Diabetes, Endocrinology and Metabolic Diseases
Barbara Linder, M.D. Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301 594-0021 Email: linderb@mail.nih.gov Division of Kidney, Urologic and Hematologic Diseases Tracy L. Rankin, M.P.H, Ph.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301 594-4748 Email: rankint@mail.nih.gov Division of Digestive Diseases and Nutrition Aynur Unalp-Arida, M.D., Ph.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301 594-8879 Email: aynur.unalp-arida@nih.gov NIDDK accepts applications for low risk clinical trials in its mission. Please see NOT-DK-21-004 for further information.
|
Mary K. Rosenberg
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301-594-8891
Email: RosenbergM@extra.niddk.nih.gov |
|
National Institute of Environmental Health Sciences (NIEHS) | Bonnie Joubert, Ph.D. Telephone: 984-287-3275 Email: bonnie.joubert@nih.gov https://www.niehs.nih.gov/funding/grants/announcements/index.cfm |
Aaron Nicholas Telephone: 984-287- 3297 Email: Aaron.Nicholas@nih.gov |
|
National Institute of General Medical Sciences (NIGMS) |
As announced in NOT-GM-22-027, NIGMS will accept applications in response applications to the NIH Parent (R01 Clinical Trial Required) FOA that propose:
|
NIGMS supports investigator-initiated research in the following clinical research
areas: Anesthesiology and Pain Zuzana Justinova, M.D., Ph.D. Email: zuzana.justinova@nih.gov Clinical Pharmacology Martha Garcia, Ph.D. Email: martha.garcia@nih.gov Sepsis Xiaoli Zhao, Ph.D. Email: xiaoli.zhao@nih.gov Innate Immunity and Inflammation Xiaoli Zhao, Ph.D. & Shakira Nelson, Ph.D. Email: xiaoli.zhao@nih.gov Email: shakira.nelson@nih.gov Injury and Critical Illness Chris Chao, Ph.D. Email: chris.chao@nih.gov Wound Healing Martha Garcia, Ph.D. Email: martha.garcia@nih.gov Additional information is available on the NIGMS website on Clinical Studies and Trials. Contacts for other research areas at NIGMS are at: Contacts by Research Area. Lisa Moeller Email: lm236j@nih.gov |
|
National Institute of Mental Health (NIMH) | As stated in NOT-MH-19-031, NIMH only accepts clinical trial applications proposing
mechanistic studies under the Parent R01 Clinical Trial Required (PA-19-055). For consideration by the
NIMH, applicants who wish to submit clinical trials that propose to test efficacy, effectiveness or
safety should not submit to this FOA. Instead, clinical trials testing efficacy, effectiveness or safety
must be submitted to one of the FOAs listed here: Clinical Trials FOAs.
Applicants are strongly advised to consult with NIMH program staff prior to submitting an application
with human subjects to determine the appropriate funding opportunity announcement. Aileen Schulte, PhD Telephone: 301-443-1225 Email: aschulte@mail.nih.gov |
Terri Jarosik National Institute of Mental Health (NIMH) Telephone: (301) 443-3858 Email: tjarosik@mail.nih.gov |
|
National Institute on Minority Health and Health Disparities (NIMHD) | The National Institute on Minority Health and Health Disparities (NIMHD) will accept
investigator-initiated research projects (R01) for all program areas supported by the
Institute. Please click on links below for descriptions of NIMHD’s main research interest areas and contact information for a scientific program contact in each area: Community Health and Population Sciences Clinical and Health Services Research Integrative Biological and Behavioral Sciences |
Priscilla Grant, JD Telephone: 301-594-8412 Email: pg38h@nih.gov |
|
National Institute of Neurological Disorders and Stroke (NINDS) |
Rebecca Hommer, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Phone: 301-827-2257
E-mail: Rebecca.hommer@nih.gov
As announced in NOT-NS-18-011, NINDS only accepts clinical trial applications proposing mechanistic studies for the Clinical Trial Required Parent R01 (PA-18-345). Applications that include a prospective biomedical or behavioral research study of human subjects that is designed to answer specific questions about pharmacologic, behavioral, biologic, surgical, or device interventions should be submitted to an NINDS clinical trial-specific funding announcement (listed on the NINDS website at Clinical Research). Applicants are strongly advised to consult with NINDS program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity. |
Chief Grants Management Officer National Institute of Neurological Disorders and Stroke (NINDS) Email: ChiefGrantsManagementOfficer@ninds.nih.gov |
|
National Institute of Nursing Research (NINR) | The National Institute of Nursing Research (NINR) will accept applications for projects in areas that are mission-relevant (http://www.ninr.nih.gov/AboutNINR/NINRMissionandStrategicPlan/). Please contact the NINR Program Director listed in the area of science in which you are interested. NINR Program Staff contacts may be found at: https://www.ninr.nih.gov/researchandfunding/desp/oep/areasofscience | Brian Albertini Telephone: 301-594-6869 Email: albertib@mail.nih.gov |